Tradition Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Tradition Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-75	Closed	-$47K	–	1190
2021 Q4	$47K	Hold	75	–	–	0.01%	541
2021 Q3	$45K	Hold	75	–	–	0.01%	530
2021 Q2	$42K	Hold	75	–	–	0.01%	571
2021 Q1	$35K	Hold	75	–	–	0.01%	517
2020 Q4	$36K	Buy	+75	New	+$40.5K	0.01%	472

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tradition Wealth Management's REGN Position: Q1 2022 in Review

Tradition Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2022, closing a stake of 75 shares — an estimated $47K sold.

Tradition Wealth Management first reported a position in REGN in Q4 2020 and held it in 5 quarters. The position peaked at $47K in Q4 2021. 1,095 funds tracked by Wall St. Rank hold REGN as of Q1 2022.

Tradition Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Tradition Wealth Management sold 75 Regeneron Pharmaceuticals shares in Q1 2022, an estimated $47K.
Tradition Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2020 and held it in 5 quarters.
Tradition Wealth Management's Regeneron Pharmaceuticals position peaked at $47K in Q4 2021.
1,095 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2022.

Based on Tradition Wealth Management's 13F filing for Q1 2022, filed 11 May 2022.